# US 2026/0085389 A1 · High entropy alloy for bioimplant applications

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0085389 A1
- Document ID: US20260085389A1
- Status: Published application
- Kind: A1
- Application number: 18/893,114
- Filed: 2024-09-23
- Published: 2026-03-26
- Earliest claimed: 2024-09-23
- Assignees: King Fahd University of Petroleum and Minerals
- Applicants: King Fahd University of Petroleum and Minerals
- Inventors: Mohamed Abdrabou HUSSEIN; Mohammed Abdul AZEEM; Arumugam Madhan KUMAR
- Web page: https://patentgrep.com/patent/US20260085389A1

## CPC

- C22C 30/00: Alloys containing less than 50% by weight of each constituent
- A61F 2/30: Joints
- B22F 9/04: starting from solid material, e.g. by crushing, grinding or milling ({C22C1/1084 takes precedence}; crushing, grinding or milling, in general, see the relevant subclasses, e.g. B02C)
- C22C 1/04: by powder metallurgy (C22C1/08 takes precedence)
- C22C 1/0458: {Alloys based on titanium, zirconium or hafnium}
- C22C 14/00: Alloys based on titanium
- B22F 2009/043: {by ball milling}
- C22C 2200/00: Crystalline structure
- C22C: ALLOYS (treatment of alloys C21D, C22F)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- B22F: WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER (making alloys by powder metallurgy C22C); APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER

## Abstract

A non-equiatomic high entropy alloy (HEA) includes titanium in an amount of 33 to 37 atomic percent, zirconium in an amount of 33 to 37 atomic percent, niobium in an amount of 18 to 22 atomic percent, tantalum in an amount of 3 to 7 atomic percent, and silver in an amount of 3 to 7 atomic percent, wherein atomic percent is based on the total atom count of the HEA. The elements titanium, zirconium, niobium, tantalum, and silver are randomly distributed within the HEA. A method of preparation thereof and its use thereof as a bioimplant with improved corrosion resistance, anti-bacterial properties, and reduced elastic modulus.

## Claims

### Claim at position 1

1: A non-equiatomic high entropy alloy, comprising:
titanium in an amount of 33 to 37 atomic percent;
zirconium in an amount of 33 to 37 atomic percent;
niobium in an amount of 18 to 22 atomic percent;
tantalum in an amount of 3 to 7 atomic percent; and
silver in an amount of 3 to 7 atomic percent;
wherein atomic percent is based on the total atom count of the non-equiatomic high entropy alloy,
wherein the titanium, zirconium, niobium, tantalum, and silver are randomly distributed within the non-equiatomic high entropy alloy.

### Claim at position 2 (depends on 1)

2: The non-equiatomic high entropy alloy of claim 1, wherein the alloy is made by a process comprising:
mixing a titanium powder, a zirconium powder, a niobium powder, a tantalum powder, and a silver powder to form a first mixture;
ball-milling the first mixture for 16 to 24 hours at a speed of 250 to 350 rpm;
pressing the first mixture at a pressure of 500 to 750 MPa; and
sintering the first mixture to a temperature of 1250 to 1350° C. to form the alloy.

### Claim at position 3 (depends on 2)

3: The non-equiatomic high entropy alloy of claim 2, wherein the ball-milling has a bypass ratio of 5:1 to 15:1 in an inert environment.

### Claim at position 4 (depends on 2)

4: The non-equiatomic high entropy alloy of claim 2, wherein, after the pressing, the sintering includes heating the first mixture to a temperature of 1250 to 1350° C. at a rate of 8 to 12° C./min to form the alloy.

### Claim at position 5 (depends on 2)

5: The non-equiatomic high entropy alloy of claim 2, wherein the sintering occurs for 1 to 3 hours.

### Claim at position 6 (depends on 1)

6: The non-equiatomic high entropy alloy of claim 1, wherein the alloy has a valence electron concentration of 3 to 5.

### Claim at position 7 (depends on 1)

7: The non-equiatomic high entropy alloy of claim 1, wherein the alloy has an atomic-size difference (6) of 4 to 6%.

### Claim at position 8 (depends on 1)

8: The non-equiatomic high entropy alloy of claim 1, wherein the alloy has an omega (Q) parameter of 10 to 11.

### Claim at position 9 (depends on 1)

9: The non-equiatomic high entropy alloy of claim 1, wherein the alloy comprises a major body-centered cubic 1 (bcc1) phase, a grain boundary body-centered cubic 2 (bcc2) phase, and an ultra-fine zirconium-rich equiaxed phase.

### Claim at position 10 (depends on 1)

10: The non-equiatomic high entropy alloy of claim 1, wherein the alloy has a grain size of 1 to 2 μm.

### Claim at position 11 (depends on 1)

11: The non-equiatomic high entropy alloy of claim 1, wherein the alloy has a crystallite size of 3 to 4 nm.

### Claim at position 12 (depends on 1)

12: The non-equiatomic high entropy alloy of claim 1, wherein the alloy has a melting temperature of 2150 to 2250 K.

### Claim at position 13 (depends on 1)

13: The non-equiatomic high entropy alloy of claim 1, wherein the alloy has a density of 6.5 to 7.5 g/cm3.

### Claim at position 14 (depends on 1)

14: The non-equiatomic high entropy alloy of claim 1, wherein the alloy has a Vickers microhardness of 3 to 6 GPa.

### Claim at position 15 (depends on 1)

15: The non-equiatomic high entropy alloy of claim 1, wherein the alloy has an elastic modulus of 80 to 120 GPa.

### Claim at position 16 (depends on 1)

16: The non-equiatomic high entropy alloy of claim 1, wherein a rate of antibacterial inhibition of the alloy in the presence of Bacillus subtilis is 90 to 94% greater compared a rate of antibacterial inhibition of a commercially pure titanium sample.

### Claim at position 17 (depends on 1)

17: The non-equiatomic high entropy alloy of claim 1, wherein a rate of antibacterial inhibition of the alloy in the presence of Escherichia coli is 83 to 90% greater compared a rate of antibacterial inhibition of a commercially pure titanium sample.

### Claim at position 18 (depends on 1)

18: The non-equiatomic high entropy alloy of claim 1, wherein the alloy has an impedance value of 70,000 to 300,000 Ω cm2 in a stimulate body fluid medium.

### Claim at position 19 (depends on 1)

19: The non-equiatomic high entropy alloy of claim 1, wherein the alloy has a phase angle of −75° to −85° in a stimulate body fluid medium.

### Claim at position 20 (depends on 1)

20: A bioimplant material, comprising:
the non-equiatomic high entropy alloy of claim 1.
